Concepedia

HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab

Elaine Chang, Gustavo Rivero, Niraj R. Patel, Elizabeth Y. Chiao, Syeling Lai, Kelash Bajaj, John E. Mbue, Sarvari V. Yellapragada

Clinical Lymphoma Myeloma & Leukemia · 2018 · 19 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Revised Response Criteria for Malignant Lymphoma

Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text

, , +15

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello et al. · New England Journal of Medicine · 2014 · 3.5K citations · Full text

, , +17

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Cheryl L. Day, Daniel E. Kaufmann, Photini Kiepiela et al. · Nature · 2006 · 2.6K citations

, , +17

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Lydie Trautmann, Loury Janbazian, Nicolas Chomont et al. · Nature Medicine · 2006 · 1.5K citations

, , +17

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

Anas Younes, Armando Santoro, Margaret A. Shipp et al. · The Lancet Oncology · 2016 · 924 citations · Full text

, , +16